PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)

NCT00182364 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Critically Ill
Deep Venous Thrombosis

Interventions

DRUG: Fragmin (Dalteparin) LMWH verus Unfractionated Heparin (UFH)

Sponsor

Hamilton Health Sciences Corporation

Collaborators

[object Object]
[object Object]